Market Update (NYSE:MRK): Merck, Glaxo end co-pay assistance for Obamacare plans

[Reuters] – Merck and Co Inc and GlaxoSmithKline Plc are not reimbursing drug co-payments for patients who purchase their health insurance through state and federal exchanges set up under the Obamacare program. The . . . → Read More: Market Update (NYSE:MRK): Merck, Glaxo end co-pay assistance for Obamacare plans Similar Articles: Stock Update: Merck & Co Inc (NYSE:MRK) – Merck and Endocyte Announce European CHMP Positive Opinions for VYNFINIT® (vintafolide) and Companion Imaging Agents FOLCEPRI® (etarfolatide) and NEOCEPRI® (Intravenous (IV) folic acid) in Patients with Platinum-Resistant … Company Update (NYSE:MRK): Merck to Hold First-Quarter 2014 Sales and Earnings Conference Call on April 29 Merck & Co. Inc. (NYSE:MRK) – Keep an Eye on Biogen, Johnson & Johnson, and Merck Today